Application of JAK1 Inhibitors in Peripheral T-cell Lymphoma: Highlights from the 15th Chinese Medical Association Hematology Academic Conference and the First Rare Blood Disease Academic Conference

Application of JAK1 Inhibitors in Peripheral T-cell Lymphoma: Highlights from the 15th Chinese Medical Association Hematology Academic Conference and the First Rare Blood Disease Academic Conference

From March 23rd to 24th, 2024, the 15th Chinese Medical Association Hematology Academic Conference and the First Rare Blood Disease Academic Conference, hosted by the Chinese Medical Association and the Hematology Branch of the Chinese Medical Association, and co-organized by the First Affiliated Hospital of Soochow University, was successfully held in Suzhou, Jiangsu Province, China. Numerous hematological experts and scholars from China and abroad engaged in academic exchanges on experimental diagnosis in the field of hematological diseases and the latest developments in rare blood diseases through academic presentations and thematic discussions.During the conference, Professor Bing Xiang from West China Hospital of Sichuan University delivered an insightful presentation titled "Application of JAK1 Inhibitors in Peripheral T-cell Lymphoma." In this article, we summarize the main points of the presentation for the benefit of our readers.